TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010
TCL Archive FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart December 3, 2010
TCL Archive In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX May 5, 1995
